A very bullish analyst move was the news generally responsible for Summit Therapeutics' (NASDAQ: SMMT) healthy mid-week stock price pop. The person behind the news was Evercore ISI pundit Cory Kasimov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback